CMECNECE

Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Overview

Author(s)/Faculty: Rishi P. Singh, MD; Davida F. Kruger, MSN, APN-BC, BC-ADM; Mark H. Schutta, MD; Linda E. Sartor, RD, CDE, LDN
Source: Healio - Endocrinology Education Lab
Type: MonographArticles/Items: 8
Release Date: 8/10/2016Expiration Date: 8/10/2017
Credit Type: CME / CNE / AANP / AAPANumber of Credits: 1.5
Cost: FreeProvider: Vindico Medical Education
Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence of DR in this population is increasing; it currently affects over 4 million people, and it is projected that this figure will rise to 6 million people by the year 2020. Diabetic retinopathy is a treatable condition, and both the prevalence and the rate of progression of the disease can be reduced with cooperation between a knowledgeable clinician, as well as a motivated and aware patient. Outcomes can be optimized if the clinician employs guideline-directed screening procedures to detect early signs of retinopathy in patients with diabetes, ensuring that timely prevention and treatment measures are put into place. This CME/CNE/CE monograph will review the etiology and pathophysiology of DR, evaluate evidence-based guidelines for DR screening and referral, as well as assess best practices in multidisciplinary management and follow-up care for patients who are risk for DR.

CME Information

page 1 of 11